Financial Daily from THE HINDU group of publications
Thursday, Nov 13, 2003

News
Features
Stocks
Port Info
Archives

Group Sites

Corporate - Awards & Honours


Natco bags award for cancer drug research

Our Bureau

Hyderabad , Nov. 12

AFTER bagging the Department of Scientific and Industrial Research (DSIR) annual award for its research & development efforts, Natco Pharma Ltd (NPL), the city-based integrated pharmaceutical company, has now won the award in `Best technology development in R&D' from the Federation of Andhra Pradesh Chamber of Commerce and Industry (FAPCCI).

In a press release, NPL said it was chosen for the FAPCCI annual award for its efforts made in R&D, especially in the successful development and commercialisation of an innovative technology for the manufacture of Imatinib Mesylate, an anti-cancer drug.

According to the company, the award would be presented at the ensuing annual function and awards distribution of FAPCCI, the date of which was yet to be announced. Natco, the manufacturer of finished dosage forms, active pharmaceutical ingredients, advanced intermediates and custom-manufactured speciality chemicals, has applied for an international patent for the method of manufacture of Imatinib Mesylate.

Article E-Mail :: Comment :: Syndication

Stories in this Section
Linc Pen to manufacture Mitsubishi products


No plans to set up unit in US now: Elgi
Novartis receives exclusive marketing rights for Glivec
Residency Hotel to offer service apartments
LG Pune factory to be made export hub
Handicrafts Export Corpn presents dividend cheque
Apollo Hospitals brings out CD on laparoscopic surgery
Natco to challenge grant of exclusive rights to Novartis cancer drug
Norms tightened for external borrowings — End-use conditions read tough
Corporates yet to heed RBI advice on hedging exposures
BPL to raise $100 m from external borrowing for turnaround
Natco bags award for cancer drug research
Udyog Ratna Award
RPG plans VRS for group cos; to expand retail biz
CESC VRS: `Early bird scheme evokes good response'
`HRM needs a re-look'
3 FIIs pick 4.6% promoters' stake in Pantaloon Retail
OVL to remain flagship for investments abroad
HNL staff hold picketing at Piravom Road Railway Station
Shalimar Paints in talks with 2 global majors — Plans strategic tie-ups in non-decorative coatings
Aventis scheme for osteoporosis patients
Tata Steel coal unit gets `Qimpro Benchmark'
Tata Steel banks on carbon trading to fund expansion
Metso to expand paper equipment biz in India


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | Home |

Copyright 2003, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line